Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models” by Ashleigh R. Price, Guilian Xu, Zoe B. Siemienski,

Slides:



Advertisements
Similar presentations
Comparison of Plaque Burden in Tg2576 Mice Using the Aperio and TurboScan Imaging Platforms A.J. Milici.
Advertisements

Supplemental Figure 1. Remicade treatment did not affect body weight and muscle weight in mdx mice. Mdx mice were treated with Remicade (10 mg/ml) starting.
Comment on “ApoE-Directed Therapeutics Rapidly Clear β- Amyloid and Reverse Deficits in AD Mouse Models” by Ina Tesseur, Adrian C. Lo, Anouk Roberfroid,
Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models” by Karthikeyan Veeraraghavalu, Can Zhang, Sean.
Volume 1, Issue 3, Pages (November 2015)
Beneficial synergistic effects of microdose lithium with pyrroloquinoline quinone in an Alzheimer's disease mouse model  Lei Zhao, Neng Gong, Meng Liu,
Development of a Rab9 Transgenic Mouse and Its Ability to Increase the Lifespan of a Murine Model of Niemann-Pick Type C Disease  Tatiana Kaptzan, Sally.
Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer  Lanxi Song, MS, Matthew A. Smith, PhD,
Volume 24, Issue 5, Pages (November 2013)
Athena Kalyvas, Samuel David  Neuron 
Volume 137, Issue 2, Pages e2 (August 2009)
Fig. 6. AZD6738 induces DNA damage and apoptosis and exhibits antitumor efficacy in xenograft models of high-risk medulloblastoma and neuroblastoma. AZD6738.
Jurian Schuijers, Laurens G. van der Flier, Johan van Es, Hans Clevers 
Volume 90, Issue 5, Pages (June 2016)
Loss of STAT1 is associated with increased aortic rupture in an experimental model of aortic dissection and aneurysm formation  Matthew J. Eagleton, MD,
Volume 19, Issue 4, Pages (October 1997)
Inhibition of UVB-Induced Skin Tumor Development by Drinking Green Tea Polyphenols Is Mediated Through DNA Repair and Subsequent Inhibition of Inflammation 
Fig. 4. Bexarotene promotes PPARδ activation of target genes in mouse brain and muscle. Bexarotene promotes PPARδ activation of target genes in mouse brain.
Volume 132, Issue 5, Pages (May 2007)
Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent manner. Combined PLX3397 and PTX treatment inhibits metastasis in a CD8-dependent.
Volume 18, Issue 5, Pages (May 2010)
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.
Fig. 6. Treatment with a DLK inhibitor is neuroprotective and reverses stress-induced gene expression changes. Treatment with a DLK inhibitor is neuroprotective.
Volume 7, Issue 4, Pages (October 2016)
Volume 126, Issue 5, Pages (May 2004)
Analysis of brain and spinal cord of treated Gaa−/− mice and controls
Volume 44, Issue 2, Pages (October 2004)
Fig. 5. Pharmacological JAK2 inhibition in vivo abrogates tumor-initiating potential after chemotherapy. Pharmacological JAK2 inhibition in vivo abrogates.
Volume 30, Issue 3, Pages (May 2001)
Volume 17, Issue 9, Pages (September 2010)
ApoE4 Accelerates Early Seeding of Amyloid Pathology
Oral Administration of Recombinant Adeno-associated Virus-mediated Bone Morphogenetic Protein-7 Suppresses CCl4-induced Hepatic Fibrosis in Mice  Zhi-Ming.
by Ling-juan Zhang, Christian F. Guerrero-Juarez, Tissa Hata, Sagar P
Fig. 1. Muscles of LAMA2 MD patients and dyW/dyW mice contain high amounts of laminin-α4 and show deficits in BM. Muscles of LAMA2 MD patients and dyW/dyW.
Volume 49, Issue 5, Pages (March 2006)
Volume 78, Issue 4, Pages (May 2013)
Volume 44, Issue 2, Pages (October 2004)
Role of meprin A in renal tubular epithelial cell injury
Arc expression increases H4K12Ac levels.
Molecular and morphological analysis of Pitrm1+/− mouse brain
Volume 72, Issue 3, Pages (August 2007)
Molecular Therapy - Methods & Clinical Development
Volume 71, Issue 5, Pages (September 2011)
Volume 64, Issue 5, Pages (December 2009)
Fig. 3 Hepatic HBV envelope RNA and protein expression levels in HBVRplRag−/− mice 7 days (1 week) and 8 to 24 weeks after adoptive transfer with WT or.
Fig. 1. Bexarotene promotes PPARδ activation to ameliorate the neurotoxicity of mutant huntingtin. Bexarotene promotes PPARδ activation to ameliorate the.
Increased Expression of Wnt2 and SFRP4 in Tsk Mouse Skin: Role of Wnt Signaling in Altered Dermal Fibrillin Deposition and Systemic Sclerosis  Julie Bayle,
Bexarotene is neuroprotective in mouse and human HD neurons in vitro
Fig. 4. Acute lung injury in miR-223−/y mice.
Fig. 6 Combination therapy with LVSOD2 and LVshCTGF preserves flap volume and reduces fibrosis after RT. Combination therapy with LVSOD2 and LVshCTGF preserves.
Volume 18, Issue 3, Pages (March 2010)
Bile acids regulate the ontogenic expression of ileal bile acid binding protein in the rat via the farnesoid X receptor  Sandy T. Hwang, Nancy L. Urizar,
Volume 13, Issue 3, Pages (March 2006)
Volume 71, Issue 5, Pages (September 2011)
Figure 1 A B GCL NBL ED18.5 PND3 PND6 GCL
Volume 55, Issue 2, Pages (February 1999)
Fragment N expression does not affect islet morphology and cellularity
The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma
Fig. 2. Deficiency of neuronal HS leads to reduced neuroinflammation.
Figure 1 A B GCL NBL ED18.5 PND3 PND6 GCL
Aβ-mediated Ras-MAPK signaling and Cyclin D1 expression in B103 cells are dependent on APP expression and can be reversed with MEK or Ras inhibition. Aβ-mediated.
Oligomeric Aβ42 treatment induces expression of Ras and Cyclin D1 and activation of ERK in primary rat cortical neurons. Oligomeric Aβ42 treatment induces.
Ju Youn Beak et al. BTS 2017;2:39-53
TOMA does not affect NFTs in posterior hypothalamus or cortex.
Combination extract inhibits NF-κB activation in intestine, liver, testis, and epididymis. Combination extract inhibits NF-κB activation in intestine,
Microfluidic platform for cell phenotype and gene function analysis
Pioglitazone induces the clearance of amyloid in APP/PS1 mice.
Effects of ZOL treatment on pulmonary metastases.
GCS-100 selectively kills KRAS-addicted lung tumors.
Fig. 2. SUS reduces Aβ plaques in an AD mouse model.
Presentation transcript:

Comment on “ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models” by Ashleigh R. Price, Guilian Xu, Zoe B. Siemienski, Lisa A. Smithson, David R. Borchelt, Todd E. Golde, and Kevin M. Felsenstein Science Volume 340(6135):924-924 May 24, 2013 Published by AAAS

Fig. 1 Aβ levels and plaque burden are unchanged by bexarotene treatment.APP/PS1ΔE9 mice (7 and 11 months old, including both male and female; n = 5 to 6 per treatment group) were dosed with bexarotene (100 mg/kg per day) or vehicle by oral gavage for 7 days. Aβ levels and plaque burden are unchanged by bexarotene treatment.APP/PS1ΔE9 mice (7 and 11 months old, including both male and female; n = 5 to 6 per treatment group) were dosed with bexarotene (100 mg/kg per day) or vehicle by oral gavage for 7 days. Upon harvest, one hemibrain was frozen in liquid nitrogen, with the other fixed in 4% paraformaldehyde with 0.1 M phosphate buffer, pH 7.6, for histological analysis. (A) The frozen hemibrains were sequentially extracted essentially as previously described (9), using RIPA detergent followed by 2% SDS followed by 70% formic acid. The resulting extracts were analyzed for soluble and insoluble Aβ40 and Aβ42 by differential enzyme-linked immunosorbent assay. Bexarotene and vehicle treatment is shown by the black and gray bars, respectively. (B) Representative cortical sections of bexarotene- or vehicle-treated mice stained with thioflavin S (inset represents magnified image of a typical plaque). (C) Images of sections immunostained with panAβ1-16 antibody 33.1.1 (15); similar results are also seen by silver staining, antibody 6E10, or an Aβ42-specific antibody (data not shown). (D) Quantitation of the plaque numbers. The fluorescent images were scanned using a ScanScope FL (Aperio Technologies). The cortex was outlined, and the numbers of amyloid plaques per mm2 of the cortex were manually counted by an observer blinded to treatment. 7-month-old vehicle-treated = 26.8 ± 4.2 plaques; 7-month-old bexarotene-treated = 19 ± 5.6; 11-month vehicle-treated = 54.8 ± 7.3; 11-month bexarotene-treated = 59.3 ± 7.7; error bars, mean ± SEM; no statistical significance between the groups by Student’s t test. The Aβ burden as percentage of total area was determined using the ImageScope program and Positive Pixel Count Algorithm (Aperio Technologies) from antibody 33.1.1 stained sections (using the average of three sections per brain 30 μm apart), with no statistical significance between the groups. 7-month-old vehicle-treated = 1.0 ± 0.6; 7-month-old bexarotene-treated = 0.7 ± 0.35; 11-month-old vehicle-treated = 2.3 ± 0.8; 11-month-old bexarotene-treated = 2.1 ± 0.8. Ashleigh R. Price et al. Science 2013;340:924 Published by AAAS

Fig. 2 Short-term bexarotene treatment stimulates the expression of LXR target genes in vivo.Brain homogenates from the 11-month-old bexarotene- and vehicle-treated (n = 5 mice) animals made in RIPA lysis buffer were analyzed on Western blot and probed with an antibody specific either for apoE or for ABCA1, along with an internal control for actin. Short-term bexarotene treatment stimulates the expression of LXR target genes in vivo.Brain homogenates from the 11-month-old bexarotene- and vehicle-treated (n = 5 mice) animals made in RIPA lysis buffer were analyzed on Western blot and probed with an antibody specific either for apoE or for ABCA1, along with an internal control for actin. Proteins were quantitated and normalized to actin using an Odyssey LiCor Imager, with results summarized in the accompanying graph. Also shown are the change in liver weights of the two groups (Student’s t test; error bars, mean ± SEM, **P < 0.01, ***P < 0.001). Similar results were seen with the 7-month-old animals; data not shown. Ashleigh R. Price et al. Science 2013;340:924 Published by AAAS